[HTML][HTML] Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here?

K Mallah, C Couch, DM Borucki, A Toutonji… - Frontiers in …, 2020 - frontiersin.org
Neurological disorders are major contributors to death and disability worldwide. The
pathology of injuries and disease processes includes a cascade of events that often involve …

[HTML][HTML] Experimental and clinical biomarkers for progressive evaluation of neuropathology and therapeutic interventions for acute and chronic neurological disorders

DS Reddy, HN Abeygunaratne - International Journal of Molecular …, 2022 - mdpi.com
This article describes commonly used experimental and clinical biomarkers of neuronal
injury and neurodegeneration for the evaluation of neuropathology and monitoring of …

Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches

NK Prabhakar, H Khan, AK Grewal, TG Singh - International …, 2022 - Elsevier
TBI has been one of the top causes of death and morbidity worldwide, yet despite enormous
efforts to discover neuroprotective therapeutics for this serious disease, no beneficial …

Building a bridge between NMDAR-mediated excitotoxicity and mitochondrial dysfunction in chronic and acute diseases

RG Mira, W Cerpa - Cellular and Molecular Neurobiology, 2021 - Springer
Glutamate is the major excitatory neurotransmitter in the brain, and it is widely accepted to
play a role in synaptic plasticity and excitotoxic cell death. Glutamate binds to several …

Protective effect of d-alanine against acute kidney injury

Y Iwata, Y Nakade, S Kitajima… - American Journal …, 2022 - journals.physiology.org
Recent studies have revealed the connection between amino acid chirality and diseases.
We have previously reported that the gut microbiota produces various d-amino acids in a …

Emerging potential of cannabidiol in reversing proteinopathies

R Dash, MC Ali, I Jahan, YA Munni, S Mitra… - Ageing research …, 2021 - Elsevier
The aberrant accumulation of disease-specific protein aggregates accompanying cognitive
decline is a pathological hallmark of age-associated neurological disorders, also termed as …

[HTML][HTML] Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases

MS Attia, A Yahya, NA Monaem, SA Sabry - Saudi Pharmaceutical Journal, 2023 - Elsevier
Worldwide, populations face significant burdens from neurodegenerative disorders (NDDs),
especially Alzheimer's and Parkinson's diseases. Although there are many proposed …

Iron pathophysiology in Alzheimer's diseases

T Wang, SF Xu, YG Fan, LB Li, C Guo - Brain iron metabolism and CNS …, 2019 - Springer
Alzheimer's disease (AD) is a multifactorial neurodegenerative condition associated with
pathological accumulation of amyloid plaques and with the appearance of deposit of …

[HTML][HTML] Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells

W Zhang, PJ Ross, J Ellis, MW Salter - Translational psychiatry, 2022 - nature.com
NMDA receptors (NMDARs), a prominent subtype of glutamatergic receptors, are implicated
in the pathogenesis and development of neuropsychiatric disorders such as epilepsy …

Collateral circulation augmentation and neuroprotection as adjuvant to mechanical thrombectomy in acute ischemic stroke

SM Desai, RM Jha, I Linfante - Neurology, 2021 - AAN Enterprises
Purpose of the Review Mechanical thrombectomy (MT)–mediated endovascular
recanalization has dramatically transformed treatment and outcomes after acute ischemic …